Patent · US Active

Extended release biodegradable ocular implants

US8895049B2 · kind B2 · utility

1Cited by

23References

5Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Thierry Nivaggioli · San Francisco, US
Jane-Guo Shiah · Irvine, US
Qing Lin · San Diego, US

Key dates

Filing date	Oct 8, 2013
Grant date	Nov 25, 2014
Priority date	—
Expiry date	Oct 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/204
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.